Tacita Capital Inc Reduces Position in MetLife, Inc. (NYSE:MET)

Tacita Capital Inc trimmed its holdings in shares of MetLife, Inc. (NYSE:MET) by 40.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 525 shares of the financial services provider’s stock after selling 350 shares during the quarter. Tacita Capital Inc’s holdings in MetLife were worth $43,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Fidelis Capital Partners LLC increased its position in shares of MetLife by 7.0% during the fourth quarter. Fidelis Capital Partners LLC now owns 3,472 shares of the financial services provider’s stock worth $297,000 after acquiring an additional 228 shares during the last quarter. SBI Securities Co. Ltd. purchased a new stake in shares of MetLife during the fourth quarter worth about $110,000. Jones Financial Companies Lllp increased its position in shares of MetLife by 30.5% during the fourth quarter. Jones Financial Companies Lllp now owns 19,673 shares of the financial services provider’s stock worth $1,611,000 after acquiring an additional 4,594 shares during the last quarter. Modera Wealth Management LLC increased its position in shares of MetLife by 6.4% during the fourth quarter. Modera Wealth Management LLC now owns 2,842 shares of the financial services provider’s stock worth $233,000 after acquiring an additional 172 shares during the last quarter. Finally, SRS Capital Advisors Inc. increased its position in shares of MetLife by 7,429.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 2,786 shares of the financial services provider’s stock worth $228,000 after acquiring an additional 2,749 shares during the last quarter. 94.99% of the stock is owned by hedge funds and other institutional investors.

MetLife Stock Performance

Shares of MET stock opened at $85.60 on Tuesday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The business has a 50 day moving average of $83.73 and a two-hundred day moving average of $82.08. The company has a market cap of $58.31 billion, a P/E ratio of 14.34, a PEG ratio of 0.65 and a beta of 1.07. MetLife, Inc. has a 52 week low of $67.30 and a 52 week high of $89.05.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be given a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.55%. MetLife’s dividend payout ratio is presently 36.52%.

Analyst Ratings Changes

Several brokerages recently weighed in on MET. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Barclays lowered their price objective on MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a report on Friday, February 7th. Wells Fargo & Company boosted their price objective on MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a report on Wednesday, February 19th. BMO Capital Markets began coverage on MetLife in a report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price objective for the company. Finally, Morgan Stanley boosted their price objective on MetLife from $101.00 to $109.00 and gave the company an “overweight” rating in a report on Friday. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat.com, MetLife presently has an average rating of “Moderate Buy” and a consensus price target of $94.58.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.